Pharmacokinetics of toxic chemicals in breast milk: use of PBPK models to predict infant exposure
about
Improving the risk assessment of lipophilic persistent environmental chemicals in breast milkRelative pesticide and exposure route contribution to aggregate and cumulative dose in young farmworker childrenThe use of physiologically based models to integrate diverse data sets and reduce uncertainty in the prediction of perchlorate and iodide kinetics across life stages and species.Collection and use of exposure data from human milk biomonitoring in the United States.Human milk biomonitoring data: interpretation and risk assessment issues.An assessment of dioxin exposure across gestation and lactation using a PBPK model and new data from Seveso.Incorporation of pharmacokinetic and pharmacodynamic data into risk assessments.Apparent half-lives of dioxins, furans, and polychlorinated biphenyls as a function of age, body fat, smoking status, and breast-feedingLevels of persistent organic pollutant and their predictors among young adults.Excretion of moxidectin into breast milk and pharmacokinetics in healthy lactating womenChildren's susceptibility to chemicals: a review by developmental stage.Mode of action: neurotoxicity induced by thyroid hormone disruption during development--hearing loss resulting from exposure to PHAHs.Lactational state modifies alcohol pharmacokinetics in women.Whole-body physiologically based pharmacokinetic models.Population physiologically based pharmacokinetic modeling for the human lactational transfer of PCB-153 with consideration of worldwide human biomonitoring results.A lifestage-specific approach to hazard and dose-response characterization for children's health risk assessment.Malaria control insecticide residues in breast milk: the need to consider infant health risks.Challenges in the application of quantitative approaches in risk assessment: a case study with di-(2-ethylhexyl)phthalate.Modeling drug passage into human milk.Editor's Highlight: Transplacental and Lactational Transfer of Firemaster® 550 Components in Dosed Wistar Rats.Developmental disruption of thyroid hormone: correlations with hearing dysfunction in rats.Fetal effects of environmental exposure of pregnant women to organophosphorus compounds in a rural farming community in Sri Lanka.Physiologically based pharmacokinetic models for the optimization of antiretroviral therapy: recent progress and future perspective
P2860
Q26849356-EFE0736E-87E0-409A-95C0-154814F4F792Q28382879-6150F4A6-1F5B-4AC0-B3AD-EE870F3AF8D3Q30763202-0F6429BA-E615-4847-BB1C-F49197BA0BACQ31006350-1A85A326-BA6E-42B0-918D-6720BE973EDCQ31006357-A21C64B7-5DF5-4698-B8C6-6F725099AA0DQ31068651-DFEA3287-9049-405D-98CE-F3167D104E52Q33519666-8F2F1D6A-BCAA-4B3B-AC54-BCF24BFEF817Q34972720-E1A43C7A-C30E-43E7-9924-66A394E849C3Q34985280-3255D65D-8383-40D7-B6AE-59CD718495FAQ35364381-E128CDB1-0894-466B-93C0-A55A93B7118AQ35977793-6FA8107D-CF2A-447E-A4CE-9C44968C7B17Q36370372-698D7E03-9749-4DDC-BFD7-D3A73B9AEC6BQ36492094-06C4C091-51CB-4ACF-8BA7-191F60BFEA36Q36788418-CED103A8-A800-41D5-83A7-149E9B54D7D2Q37007960-A390F937-0838-4804-B53C-A1B078C71DA7Q37351809-F75BC096-B16C-41F4-B4EE-4DD32B8A7101Q37465865-6B550C82-4FB1-4598-B032-06926CC694D4Q37916566-30A93A9C-A390-4287-9BC7-0D6A5F1107F9Q38802791-5A8E9EC4-6FF2-4C15-87BA-76B9F8D025EDQ41658119-FB9552AA-9CDA-4941-882E-B51279BFA213Q45231234-D8CE7E60-7B39-41CC-BCAE-D0DD0510ACD2Q46515636-1417F8FA-9155-4FE9-8DAD-1AC7AC3117DBQ58073610-61295D4D-F1CA-46A4-AA2C-0044A3BD301C
P2860
Pharmacokinetics of toxic chemicals in breast milk: use of PBPK models to predict infant exposure
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Pharmacokinetics of toxic chem ...... els to predict infant exposure
@ast
Pharmacokinetics of toxic chem ...... els to predict infant exposure
@en
Pharmacokinetics of toxic chem ...... els to predict infant exposure
@nl
type
label
Pharmacokinetics of toxic chem ...... els to predict infant exposure
@ast
Pharmacokinetics of toxic chem ...... els to predict infant exposure
@en
Pharmacokinetics of toxic chem ...... els to predict infant exposure
@nl
prefLabel
Pharmacokinetics of toxic chem ...... els to predict infant exposure
@ast
Pharmacokinetics of toxic chem ...... els to predict infant exposure
@en
Pharmacokinetics of toxic chem ...... els to predict infant exposure
@nl
P2860
P356
P1476
Pharmacokinetics of toxic chem ...... els to predict infant exposure
@en
P2093
Jeffery M Gearhart
Rebecca A Clewell
P2860
P304
P356
10.1289/EHP.021100333
P407
P577
2002-06-01T00:00:00Z